Potential natural inhibitors as strong anti‐viral agents: rigid and sequential docking analysis


Abstract views: 213 / PDF downloads: 99

Authors

Keywords:

COVID-19, DFT, Molecular docking, Phytochemicals

Abstract

Natural products have been the origin of numerous biologically active compounds in different fields, especially in the field of medicine. The synthesis of compounds produced from natural products is one approach for the wider use of natural substances in the development of new drugs. The present study accounts for the antiviral activity of most active and drug-like molecules from 14 herbal plants like ativisha, amla, aparajita, ashwagandha, kale, feverfew, giloy, adrak, kalamegha, neem, pippali, ghamra, tulsi, and turmeric. The inhibitory potential of these compounds was studied against the BF.7 variant of Omicron. The interactions of the compounds with the protein macromolecule were studied and accounted for by the hydrogen bond and hydrophobic interactions. Rigid and sequential molecular docking was performed to check the binding site on the protein and to understand the receptor-inhibitor binding mechanism. Nelfinavir, withaferin A, and hesperidin were the ligands that showed the highest binding affinities in the docking simulations (more than -10 kcal/mol). The binding mechanism of all the possible combinations of the top-ranked ligands (nelfinavir, withaferin A, and hesperidin) was analyzed using sequential docking, and the combination of withaferin A and hesperidin (W+H) was identified as the best combination with inhibition activities.

References

Agrawal, P. K., Agrawal, C., & Blunden, G. (2021). Pharmacological significance of hesperidin and hesperetin, two citrus flavonoids, as promising antiviral compounds for prophylaxis against and combating COVID-19. Natural Product Communications, 16(10), 1934578X211042540.

Barretto, N., Jukneliene, D., Ratia, K., Chen, Z., Mesecar, A. D., & Baker, S. C. (2005). The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity. Journal of Virology, 79(24), 15189-15198.

Belouzard, S., Millet, J. K., Licitra, B. N., & Whittaker, G. R. (2012). Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses, 4(6), 1011-1033.

Cavasotto, C. N., & Di Filippo, J. I. (2021). In silico drug repurposing for COVID‐19: Targeting SARS‐CoV‐2 proteins through docking and consensus ranking. Molecular Informatics, 40(1), 2000115.

Celik, I., Erol, M., & Duzgun, Z. (2021). In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase. Molecular Diversity, 26(1), 279–292.

Chafai, N., Moumeni, O., & Chafaa, S. (2023). Novel α-aminophosphonate derivates synthesis, theoretical calculation, molecular docking, and in silico prediction of potential inhibition of SARS-CoV-2. Journal of Molecular Structure, 1272, 134196.

Chang, C. K., Lo, S.-C., Wang, Y. S., & Hou, M. H. (2016). Recent insights into the development of therapeutics against coronavirus diseases by targeting N protein. Drug Discovery Today, 21(4), 562-572.

Chowdhury, P. (2021). In silico investigation of phytoconstituents from Indian medicinal herb 'Tinospora cordifolia (giloy)’against SARS-CoV-2 (COVID-19) by molecular dynamics approach. Journal of Biomolecular Structure and Dynamics, 39(17), 6792-6809.

Chowdhury, P., & Pathak, P. (2020). Neuroprotective immunity by essential nutrient “Choline” for the prevention of SARS CoV2 infections: An in silico study by molecular dynamics approach. Chemical Physics Letters, 761, 138057.

Cobre, A. D. F., Maia Neto, M., de Melo, E. B., Fachi, M. M., Ferreira, L. M., Tonin, F. S., & Pontarolo, R. (2023). Naringenin-4'-glucuronide as a new drug candidate against the COVID-19 Omicron variant: a study based on molecular docking, molecular dynamics, MM/PBSA and MM/GBSA. Journal of Biomolecular Structure and Dynamics, 1-14.

Das, P., Majumder, R., Mandal, M., & Basak, P. (2021). In-silico approach for identification of effective and stable inhibitors for COVID-19 main protease (Mpro) from flavonoid based phytochemical constituents of Calendula officinalis. Journal of Biomolecular Structure and Dynamics, 39(16), 6265-6280.

Fidan, O., Mujwar, S., & Kciuk, M. (2023). Discovery of adapalene and dihydrotachysterol as antiviral agents for the Omicron variant of SARS-CoV-2 through computational drug repurposing. Molecular Diversity, 27(1), 463-475.

Gogoi, B., Chowdhury, P., Goswami, N., Gogoi, N., Naiya, T., Chetia, P., Mahanta, S., Chetia, D., Tanti, B., et al. (2021). Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation. Molecular Diversity, 25, 1963-1977.

Gorbalenya, A. E., Baker, S. C., Baric, R. S., Groot, R. J., Drosten, C., Gulyaeva, A. A., Haagmans, B. L., Lauber, C., Leontovich, A. M., et al. (2022). The species severe acute respiratory syndrosyndrome-relatedavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology, 5, 536–544.

Guan, W.J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., He, J. X., Liu, L., Shan, H., Lei, C. l., et al. (2020). Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine, 382(18), 1708-1720.

Kandeel, M., & Al-Nazawi, M. (2020). Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease. Life Sciences, 251, 117627.

Lakhera, S., Devlal, K., Ghosh, A., Chowdhury, P., & Rana, M. (2022a). Modelling the DFT structural and reactivity study of feverfew and evaluation of its potential antiviral activity against COVID-19 using molecular docking and MD simulations. Chemical Papers, 76(5), 2759-2776.

Lakhera, S., Devlal, K., Ghosh, A., & Rana, M. (2021). In silico investigation of phytoconstituents of medicinal herb ‘Piper longum’against SARS-CoV-2 by molecular docking and molecular dynamics analysis. Results in Chemistry, 3, 100199.

Lakhera, S., Rana, M., Devlal, K., Celik, I., & Yadav, R. (2022b). A comprehensive exploration of pharmacological properties, bioactivities and inhibitory potentiality of luteolin from Tridax procumbens as anticancer drug by in-silico approach. Structural Chemistry, 33(3), 703-719.

Lee, J. E., Jeong, S. Y., Li, Z., Kim, H. Y., Kim, H. W., Yoo, M. J., Jang, H. J., Kim, D.-K., Cho, N., et al. (2023). Development of a screening platform to discover natural products active against SARS-CoV-2 infection using lung organoid models. Biomaterials Research, 27(1), 1-17.

Li, C., Ji, F., Wang, L., Wang, L., Hao, J., Dai, M., Liu, Y., Pan, X., Fu, J., et al. (2020). Asymptomatic and human-to-human transmission of SARS-CoV-2 in a 2-family cluster, Xuzhou, China. Emerging Infectious Diseases, 26(7), 1626-1628.

Malik, Y. A. (2022). Covid-19 variants: Impact on transmissibility and virulence. The Malaysian Journal of Pathology, 44(3), 387-396.

McIntyre, P., Joo, Y. J., Chiu, C., Flanagan, K., & Macartney, K. (2021). COVID-19 vaccines–are we there yet? Australian Prescriber, 44(1), 19-25.

Mohamed, E. A., Abdel-Rahman, I. M., Zaki, M. E., Al-Khdhairawi, A., Abdelhamid, M. M., Alqaisi, A. M., Rahim, L. b. A., Abu-Hussein, B., El-Sheikh, A. A., et al. (2023). In silico prediction of potential inhibitors for SARS-CoV-2 Omicron variant using molecular docking and dynamics simulation-based drug repurposing. Journal of Molecular Modeling, 29(3), 70.

Mondal, P., Natesh, J., Abdul Salam, A. A., Thiyagarajan, S., & Meeran, S. M. (2022). Traditional medicinal plants against replication, maturation and transmission targets of SARS-CoV-2: computational investigation. Journal of Biomolecular Structure and Dynamics, 40(6), 2715-2732.

Mouffouk, C., Mouffouk, S., Mouffouk, S., Hambaba, L., & Haba, H. (2021). Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CLpro and PLpro), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2). European Journal of Pharmacology, 891, 173759.

Muthumanickam, S., Kamaladevi, A., Boomi, P., Gowrishankar, S., & Pandian, S. K. (2021). Indian ethnomedicinal phytochemicals as promising inhibitors of RNA-binding domain of SARS-CoV-2 nucleocapsid phosphoprotein: an in silico study. Frontiers in Molecular Biosciences, 8, 637329.

Nugraha, A. P., Rahmadhani, D., Puspitaningrum, M. S., Rizqianti, Y., Kharisma, V. D., & Ernawati, D. S. (2021). Molecular docking of anthocyanins and ternatin in Clitoria ternatea as coronavirus disease oral manifestation therapy. Journal of Advanced Pharmaceutical Technology & Research, 12(4), 362-367.

Ouni, L., & Ramazani, A. (2023). In Silico Screening of Some Anti-Cancer Drugs Against the Main Protease of COVID-19 Using Molecular Docking. Letters in Organic Chemistry, 20(1), 77-90.

Rabie, A. M., & Eltayb, W. A. (2023). Potent dual polymerase/exonuclease inhibitory activities of antioxidant aminothiadiazoles against the COVID-19 omicron virus: a promising in silico/in vitro repositioning research study. Molecular Biotechnology, 1-20.

Rajagopal, K., Varakumar, P., Baliwada, A., & Byran, G. (2020). Activity of phytochemical constituents of Curcuma longa (turmeric) and Andrographis paniculata against coronavirus (COVID-19): an in silico approach. Future Journal of Pharmaceutical Sciences, 6, 1-10.

Rothe, C., Schunk, M., Sothmann, P., Bretzel, G., Froeschl, G., Wallrauch, C., Zimmer, T., Thiel, V., Janke, C., et al. (2020). Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. New England Journal of Medicine, 382(10), 970-971.

Shawan, M. M. A. K., Halder, S. K., & Hasan, M. A. (2021). Luteolin and abyssinone II as potential inhibitors of SARS-CoV-2: An in silico molecular modeling approach in battling the COVID-19 outbreak. Bulletin of the National Research Centre, 45(1), 1-21.

Van Doremalen, N., Bushmaker, T., Morris, D. H., Holbrook, M. G., Gamble, A., Williamson, B. N., Tamin, A., Harcourt, J. L., Thornburg, N. J., et al. (2020). Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. New England Journal of Medicine, 382(16), 1564-1567.

Veerasamy, R., & Karunakaran, R. (2022). Molecular docking unveils the potential of andrographolide derivatives against COVID-19: an in silico approach. Journal of Genetic Engineering and Biotechnology, 20(1), 1-16.

Verma, S. K., & Kumar, A. (2011). Therapeutic uses of Withania somnifera (Ashwagandha) with a note on withanolides and its pharmacological actions. Asian Journal of Pharmaceutical and Clinical Research, 4(1), 1-4.

Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., et al. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA, 323(11), 1061-1069.

Ye, G., Liu, B., & Li, F. (2022). Cryo-EM structure of a SARS-CoV-2 omicron spike protein ectodomain. Nature Communications, 13(1), 1-7.

Yu, J. W., Wang, L., & Bao, L. D. (2020). Exploring the active compounds of traditional Mongolian medicine in intervention of novel coronavirus (COVID-19) based on molecular docking method. Journal of Functional Foods, 71, 104016.

Zmudzinski, M., Rut, W., Olech, K., Granda, J., Giurg, M., Burda-Grabowska, M., Zhang, L., Sun, X., Lv, Z., et al. (2020). Ebselen derivatives are very potent dual inhibitors of SARS-CoV-2 proteases-PLpro and Mpro in in vitro studies. BioRxiv, 2020.2008. 2030.273979.

Downloads

Published

2023-09-15

How to Cite

Lakhera, S., Rana, M., & Devlal, K. (2023). Potential natural inhibitors as strong anti‐viral agents: rigid and sequential docking analysis. Life in Silico, 1(1), 34–47. Retrieved from https://life-insilico.com/index.php/pub/article/view/9

Issue

Section

Research Article